Lydia Coddens, Director Regulatory Affairs
Professional Overview
Lydia Coddens is an experienced regulatory affairs professional with a strong focus on the pharmaceutical and medical device industries. As the Director of Regulatory Affairs at Abbott, she leverages her deep expertise to navigate complex regulatory landscapes and ensure compliance across global markets.
Experience Summary
Current Role
In her current role as Director of Regulatory Affairs at Abbott, Lydia is responsible for leading a team of regulatory specialists in the Infectious Disease Emerging Markets division. She oversees the development and implementation of regulatory strategies, ensuring that all products meet stringent safety and efficacy standards set by governing bodies worldwide. Under her leadership, the team has successfully secured market authorizations for several critical medical products, enabling broader access to essential healthcare solutions.
Career Progression
Prior to her current position, Lydia held the role of Associate Director of Regulatory Operations Infectious Disease Emerging Markets at Abbott, where she spearheaded the optimization of regulatory processes and drove the successful registration of innovative infectious disease products in emerging markets. She also served as a Senior Regulatory Specialist, leveraging her in-depth knowledge of regulatory requirements to support the global expansion of Abbott's infectious disease portfolio.
Academic Background
Lydia holds a Bachelor of Science degree in Pharmaceutical Sciences from the University of Illinois at Chicago, where she graduated with distinction and was recognized for her academic excellence.
Areas of Expertise
- Regulatory strategy development and implementation
- Global market access and product registration
- Navigating complex regulatory landscapes
- Cross-functional collaboration and stakeholder management
- Leadership and team management in a dynamic, fast-paced environment
Professional Impact
Under Lydia's leadership, the Infectious Disease Emerging Markets division at Abbott has achieved significant milestones, including the successful registration of several critical medical products in high-priority markets. Her strategic guidance and innovative approach have enabled the team to enhance patient access to essential healthcare solutions, ultimately improving clinical outcomes and contributing to the advancement of global public health.
Conclusion
With her extensive experience, deep industry expertise, and proven track record of success, Lydia Coddens is a highly valuable asset to the Abbott team. She continues to drive regulatory excellence and foster a culture of compliance, positioning the organization for continued growth and innovation in the pharmaceutical and medical device sectors.
